Allergy Asthma Immunol Res. 2018 Jul;10(4):300-353. English. https://doi.org/10.4168/aair.2018.10.4.300 |
Lei Cheng,1,2,† Jianjun Chen,3,† Qingling Fu,4,† Shaoheng He,5,† Huabin Li,6,† Zheng Liu,7,† Guolin Tan,8,† Zezhang Tao,9,† Dehui Wang,6,† Weiping Wen,4,† Rui Xu,4,† Yu Xu,9,† Qintai Yang,10,† Chonghua Zhang,6,† Gehua Zhang,10,† Ruxin Zhang,11,† Yuan Zhang,12,13,14,† Bing Zhou,14,† Dongdong Zhu,15,†Luquan Chen,16 Xinyan Cui,1 Yuqin Deng,9 Zhiqiang Guo,11 Zhenxiao Huang,14 Zizhen Huang,10Houyong Li,6 Jingyun Li,12 Wenting Li,10 Yanqing Li,6 Lin Xi,12 Hongfei Lou,14 Meiping Lu,1 Yuhui Ouyang,12 Wendan Shi,9 Xiaoyao Tao,4 Huiqin Tian,1 Chengshuo Wang,14 Min Wang,12 Nan Wang,7Xiangdong Wang,12,13,14 Hui Xie,17 Shaoqing Yu,18 Renwu Zhao,11 Ming Zheng,14 Han Zhou,1 Luping Zhu,19 and Luo Zhang12,13,14 | |
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
| |
Abstract
| |
Allergic rhinitis (AR) is a global health problem that causes major illnesses and disabilities worldwide. Epidemiologic studies have demonstrated that the prevalence of AR has increased progressively over the last few decades in more developed countries and currently affects up to 40% of the population worldwide. Likewise, a rising trend of AR has also been observed over the last 2–3 decades in developing countries including China, with the prevalence of AR varying widely in these countries.
|